Cytek Biosciences is classified as operating in the Navigational, Measuring, Electromedical & Control Instruments Manufacturing industry, NAICS Code 3345.
Note: Cytek Biosciences's revenues are gauged from an analysis of company filings.
Cytek Biosciences's Income Statement (based on Industry Averages)
Cytek Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Cytek Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
November 10, 2020
14
100%
$120 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Cytek Biosciences is developing and marketing.
Cytek Biosciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SPECTROPREP Computer hardware with preinstalled software for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Downloadable computer programs for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Downloadable computer firmware for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Downloadable computer software for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Recorded computer programs for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Recorded computer firmware for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes; Recorded computer software and hardware for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes sold as a unit; Recorded computer software for the control of scientific instruments and laboratory equipment for scientific, laboratory, and general research purposes
12/18/2023
SPECTROPANEL Cloud computing featuring software for use in the field of biological science; Providing temporary use of on-line non-downloadable cloud computing software for preparation of biological science experiments
11/22/2023
IN VIVO READY Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
07/24/2023
See all trademarks and details in the Full Report.
Market Share of Cytek Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Cytek Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Cytek Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Cytek Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.